

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TCDAQ | OTC Markets | USD | Delayed | |
1T7 | Frankfurt | EUR | Delayed |
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California. On January 11, 2023, Tricida, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Name | Age | Since | Title |
---|---|---|---|
Navdeep Tangri | - | - | Member of Scientific & Clinical Advisory Board |
Thomas H. Hostetter | - | - | Member of Scientific & Clinical Advisory Board |
Bertram Pitt | - | - | Member of Scientific and Clinical Advisory Board |
Gerrit Klaerner | 50 | 2013 | Founder, President, CEO & Executive Director |
Vandana Mathur | - | - | Member of Scientific and Clinical Advisory Board |
David J. Hirsch | 51 | 2016 | Independent Non-Employee Director |
Klaus R. Veitinger | 59 | 2014 | Independent Chairman of the Board |
David Allen Bushinsky | - | - | Member of Scientific & Clinical Advisory Board |
Kathryn E. Falberg | 60 | 2018 | Independent Non-Employee Director |
Donald E. Wesson | - | 2018 | Member of Scientific & Clinical Advisory Board |
David Bonita | 45 | 2014 | Independent Non-Employee Director |
Robert J. Alpern | 71 | 2013 | Member of Scientific & Clinical Advisory Board and Independent Non-Employee Director |
Sandra I. Coufal | 58 | 2013 | Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board |
Craig J. Hawker | - | - | Member of Scientific & Clinical Advisory Board |
John S. Fordtran | - | - | Member of Scientific & Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review